324 related articles for article (PubMed ID: 20375888)
21. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Caine GJ; Stonelake PS; Lip GY; Blann AD
Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
[TBL] [Abstract][Full Text] [Related]
22. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking.
Pfaff D; Fiedler U; Augustin HG
J Leukoc Biol; 2006 Oct; 80(4):719-26. PubMed ID: 16864601
[TBL] [Abstract][Full Text] [Related]
23. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
[TBL] [Abstract][Full Text] [Related]
24. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
[TBL] [Abstract][Full Text] [Related]
26. Targeting tumor angiogenesis.
Gaur P; Bose D; Samuel S; Ellis LM
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
[TBL] [Abstract][Full Text] [Related]
27. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
[TBL] [Abstract][Full Text] [Related]
28. The expression of angiogenic growth factors and their receptors in ovarian follicles throughout the estrous cycle in the ewe.
Chowdhury MW; Scaramuzzi RJ; Wheeler-Jones CP; Khalid M
Theriogenology; 2010 Apr; 73(7):856-72. PubMed ID: 20042232
[TBL] [Abstract][Full Text] [Related]
29. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
30. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.
Eklund L; Olsen BR
Exp Cell Res; 2006 Mar; 312(5):630-41. PubMed ID: 16225862
[TBL] [Abstract][Full Text] [Related]
31. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
32. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
33. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
34. Induction of Tie-1 and Tie-2 receptor protein expression after cerebral ischemia-reperfusion.
Lin TN; Nian GM; Chen SF; Cheung WM; Chang C; Lin WC; Hsu CY
J Cereb Blood Flow Metab; 2001 Jun; 21(6):690-701. PubMed ID: 11488538
[TBL] [Abstract][Full Text] [Related]
35. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
[TBL] [Abstract][Full Text] [Related]
37. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression.
Scavelli C; Vacca A; Di Pietro G; Dammacco F; Ribatti D
Leukemia; 2004 Jun; 18(6):1054-8. PubMed ID: 15057248
[TBL] [Abstract][Full Text] [Related]
38. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.
Eklund L; Kangas J; Saharinen P
Clin Sci (Lond); 2017 Jan; 131(1):87-103. PubMed ID: 27941161
[TBL] [Abstract][Full Text] [Related]
39. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
Augustin HG; Koh GY; Thurston G; Alitalo K
Nat Rev Mol Cell Biol; 2009 Mar; 10(3):165-77. PubMed ID: 19234476
[TBL] [Abstract][Full Text] [Related]
40. Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression.
Korhonen EA; Murtomäki A; Jha SK; Anisimov A; Pink A; Zhang Y; Stritt S; Liaqat I; Stanczuk L; Alderfer L; Sun Z; Kapiainen E; Singh A; Sultan I; Lantta A; Leppänen VM; Eklund L; He Y; Augustin HG; Vaahtomeri K; Saharinen P; Mäkinen T; Alitalo K
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35763346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
